Shuster M, Lyu Z, Augenstreich J, Mathur S, Ganesh A, Ling J
Infect Immun. 2024; 92(10):e0009824.
PMID: 39269166
PMC: 11475681.
DOI: 10.1128/iai.00098-24.
Shuster M, Lyu Z, Augenstreich J, Mathur S, Ganesh A, Ling J
bioRxiv. 2024; .
PMID: 38496427
PMC: 10942315.
DOI: 10.1101/2024.03.05.583530.
Jiao H, James S, Png C, Cui C, Li H, Li L
Cell Death Differ. 2024; 31(3):280-291.
PMID: 38383887
PMC: 10923883.
DOI: 10.1038/s41418-024-01269-7.
Yaacoub C, Wehbe R, Roufayel R, Fajloun Z, Coutard B
Pathogens. 2023; 12(11).
PMID: 38003818
PMC: 10674158.
DOI: 10.3390/pathogens12111354.
Allen C, Banks D, Shuster M, Vogel S, OConnor T, Briken V
Infect Immun. 2023; 91(11):e0036523.
PMID: 37843413
PMC: 10652965.
DOI: 10.1128/iai.00365-23.
Interrupting the Conversation: Implications for Crosstalk Between Viral and Bacterial Infections in the Asthmatic Airway.
Ackland J, Watson A, Wilkinson T, Staples K
Front Allergy. 2022; 2:738987.
PMID: 35386999
PMC: 8974750.
DOI: 10.3389/falgy.2021.738987.
IFN-β Deficiency Results in Fatal or Demyelinating Disease in C57BL/6 Mice Infected With Theiler's Murine Encephalomyelitis Viruses.
Buhler M, Runft S, Li D, Gotting J, Detje C, Nippold V
Front Immunol. 2022; 13:786940.
PMID: 35222374
PMC: 8864290.
DOI: 10.3389/fimmu.2022.786940.
Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.
Salman A, Waheed M, Ali-Abdulsahib A, Atwan Z
Biomed Rep. 2021; 14(5):43.
PMID: 33786172
PMC: 7995242.
DOI: 10.3892/br.2021.1419.
Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease.
Fox L, Locke M, Lenschow D
Front Immunol. 2021; 11:606874.
PMID: 33408718
PMC: 7779635.
DOI: 10.3389/fimmu.2020.606874.
Host genetic susceptibility to viral infections: the role of type I interferon induction.
Bourdon M, Manet C, Montagutelli X
Genes Immun. 2020; 21(6-8):365-379.
PMID: 33219336
PMC: 7677911.
DOI: 10.1038/s41435-020-00116-2.
The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?.
Wu W, Metcalf J
J Innate Immun. 2020; 12(6):437-447.
PMID: 32564033
PMC: 7747089.
DOI: 10.1159/000508379.
Erucic acid from suppresses influenza A virus replication and inflammation and through modulation of NF-κB and p38 MAPK pathway.
Liang X, Huang Y, Pan X, Hao Y, Chen X, Jiang H
J Pharm Anal. 2020; 10(2):130-146.
PMID: 32373385
PMC: 7192973.
DOI: 10.1016/j.jpha.2019.09.005.
Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
Cook L, Locke M, Young A, Monte K, Hedberg M, Shimak R
J Virol. 2019; 94(1).
PMID: 31619554
PMC: 6912113.
DOI: 10.1128/JVI.00841-19.
Respiratory epithelial cells as master communicators during viral infections.
Miura T
Curr Clin Microbiol Rep. 2019; 6(1):10-17.
PMID: 31592409
PMC: 6779166.
DOI: 10.1007/s40588-019-0111-8.
Immunobiotic Strains Modulate Toll-Like Receptor 3 Agonist Induced Innate Antiviral Immune Response in Human Intestinal Epithelial Cells by Modulating IFN Regulatory Factor 3 and NF-κB Signaling.
Kanmani P, Kim H
Front Immunol. 2019; 10:1536.
PMID: 31333667
PMC: 6618302.
DOI: 10.3389/fimmu.2019.01536.
Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.
Ali S, Mann-Nuttel R, Schulze A, Richter L, Alferink J, Scheu S
Front Immunol. 2019; 10:778.
PMID: 31031767
PMC: 6473462.
DOI: 10.3389/fimmu.2019.00778.
Decoding type I and III interferon signalling during viral infection.
Mesev E, LeDesma R, Ploss A
Nat Microbiol. 2019; 4(6):914-924.
PMID: 30936491
PMC: 6554024.
DOI: 10.1038/s41564-019-0421-x.
Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival.
Banks D, Ahlbrand S, Hughitt V, Shah S, Mayer-Barber K, Vogel S
J Immunol. 2019; 202(8):2348-2359.
PMID: 30833347
PMC: 6456408.
DOI: 10.4049/jimmunol.1801303.
A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.
Shepardson K, Larson K, Cho H, Johns L, Malkoc Z, Stanek K
Viral Immunol. 2019; 32(3):131-143.
PMID: 30822217
PMC: 6479245.
DOI: 10.1089/vim.2018.0118.
Role of Type I Interferons on Filovirus Pathogenesis.
Escudero-Perez B, Munoz-Fontela C
Vaccines (Basel). 2019; 7(1).
PMID: 30791589
PMC: 6466283.
DOI: 10.3390/vaccines7010022.